Gemmothérapie Eglantier
Food supplement declared in France, decision dated 29 January 2025
Gemmothérapie Eglantier (Komorebi) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- Komorebi
- Food business operator placing the product on the market
- Amandine Béranger
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Compte-gouttes
- Daily dose
- 0,1g
- Directions for use
- 5 à 15 gouttes par jour directement en bouche ou diluées dans un peu d'eau, en dehors des repas.
- Intended populations
- Population générale, Enfants de 4 à 10 ans, Adolescents de 11 à 17 ans, Hommes et femmes de 18 ans et plus, Personnes de plus de 60 ans
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an)
- Objectives stated by the manufacturer (these are not authorised claims)
- Immunité
Declaration 87816, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Rosa canina L. | Bourgeon | Autre macérât | 20 mg |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
Other ingredients
eau de source, Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Contient de l'alcool : déconseillé aux enfants et aux femmes enceintes ou allaitantes.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- GEMMOTHÉRAPIE ÉGLANTIER PETITE SORCIÈRE, declared in 2026 : different composition: 2 ingredient(s) added, 2 missing
- Gemmothérapie Eglantier LES SENS DE THEUS, declared in 2025 : different composition: 1 ingredient(s) added, 2 missing
- Gemmothérapie Eglantier Les Jardins d'Aponi, declared in 2025 : different composition: 2 ingredient(s) added, 2 missing
- Gemmothérapie Eglantier La réserve de l’écureuil, declared in 2024 : different composition: 2 ingredient(s) added, 3 missing
- Gemmothérapie Eglantier SAS LA COTENTINE, declared in 2023 : different composition: 1 ingredient(s) added, 2 missing
- Gemmothérapie Eglantier Floralpina, declared in 2023 : different composition: 1 ingredient(s) added, 2 missing
- Gemmotherapie eglantier Au jardin de simples, declared in 2023 : different composition: 1 ingredient(s) added, 1 missing
- Gemmotherapie Eglantier Les herbes folks, declared in 2023 : different composition: 1 ingredient(s) added, 1 missing
- Gemmothérapie Eglantier LEHMANN Gwendoline, declared in 2022 : different composition: 1 ingredient(s) added, 1 missing
Brand : Komorebi
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.